130 related articles for article (PubMed ID: 8026877)
21. Frequent activation of the Ki-ras oncogene at codon 12 in N-methyl-N-nitrosourea-induced rat prostate adenocarcinomas and neurogenic sarcomas.
Sukumar S; Armstrong B; Bruyntjes JP; Leav I; Bosland MC
Mol Carcinog; 1991; 4(5):362-8. PubMed ID: 1680340
[TBL] [Abstract][Full Text] [Related]
22. Comparative study of prostatic carcinoma bone metastasis among Japanese in Japan and Japanese Americans and whites in Hawaii.
Shiraishi T; Atsumi S; Yatani R
Adv Exp Med Biol; 1992; 324():7-16. PubMed ID: 1283503
[TBL] [Abstract][Full Text] [Related]
23. K-ras activation in premalignant and malignant epithelial lesions of the human uterus.
Enomoto T; Inoue M; Perantoni AO; Buzard GS; Miki H; Tanizawa O; Rice JM
Cancer Res; 1991 Oct; 51(19):5308-14. PubMed ID: 1913654
[TBL] [Abstract][Full Text] [Related]
24. K-ras gene point mutation: a stable tumor marker in non-small cell lung carcinoma.
Li S; Rosell R; Urban A; Font A; Ariza A; Armengol P; Abad A; Navas JJ; Monzo M
Lung Cancer; 1994 Jul; 11(1-2):19-27. PubMed ID: 8081702
[TBL] [Abstract][Full Text] [Related]
25. Ras proto-oncogene activation in liver and lung tumors from B6C3F1 mice exposed chronically to methylene chloride.
Devereux TR; Foley JF; Maronpot RR; Kari F; Anderson MW
Carcinogenesis; 1993 May; 14(5):795-801. PubMed ID: 8504471
[TBL] [Abstract][Full Text] [Related]
26. The frequency of latent prostatic carcinoma in young males: the Japanese experience.
Shiraishi T; Watanabe M; Matsuura H; Kusano I; Yatani R; Stemmermann GN
In Vivo; 1994; 8(3):445-7. PubMed ID: 7803732
[TBL] [Abstract][Full Text] [Related]
27. Mutations of the p53 tumor suppressor gene and the ras gene family in intrahepatic cholangiocellular carcinomas in Japan and Thailand.
Kiba T; Tsuda H; Pairojkul C; Inoue S; Sugimura T; Hirohashi S
Mol Carcinog; 1993; 8(4):312-8. PubMed ID: 8280380
[TBL] [Abstract][Full Text] [Related]
28. K-ras point mutations in endometrial carcinoma: effect on outcome is dependent on age of patient.
Ito K; Watanabe K; Nasim S; Sasano H; Sato S; Yajima A; Silverberg SG; Garrett CT
Gynecol Oncol; 1996 Nov; 63(2):238-46. PubMed ID: 8910634
[TBL] [Abstract][Full Text] [Related]
29. The incidence of K-ras codon 12 mutations in cholangiocarcinoma detected by polymerase chain reaction technique.
Wattanasirichaigoon S; Tasanakhajorn U; Jesadapatarakul S
J Med Assoc Thai; 1998 May; 81(5):316-23. PubMed ID: 9623030
[TBL] [Abstract][Full Text] [Related]
30. K-ras codon 12 and 61 point mutations in bromodeoxyuridine- and N-nitrosomethylurea-induced rat renal mesenchymal tumors.
Calvert RJ; Buzard GS; Anisimov VN; Rice JM
Cancer Lett; 1996 Dec; 109(1-2):1-7. PubMed ID: 9020896
[TBL] [Abstract][Full Text] [Related]
31. Point mutations of the c-H-ras gene in spontaneous liver tumors of transgenic mice carrying the human c-H-ras gene.
Hayashi S; Mori I; Nonoyama T; Mitsumori K
Toxicol Pathol; 1998; 26(4):556-61. PubMed ID: 9715515
[TBL] [Abstract][Full Text] [Related]
32. Prognostic impact of mutated K-ras gene in surgically resected non-small cell lung cancer patients.
Rosell R; Li S; Skacel Z; Mate JL; Maestre J; Canela M; Tolosa E; Armengol P; Barnadas A; Ariza A
Oncogene; 1993 Sep; 8(9):2407-12. PubMed ID: 8395679
[TBL] [Abstract][Full Text] [Related]
33. A high frequency of N-RAS oncogene mutations in multiple myeloma.
Tanaka K; Takechi M; Asaoku H; Dohy H; Kamada N
Int J Hematol; 1992 Oct; 56(2):119-27. PubMed ID: 1421173
[TBL] [Abstract][Full Text] [Related]
34. Detection of K-ras oncogene mutations in bronchoalveolar lavage fluid for lung cancer diagnosis.
Mills NE; Fishman CL; Scholes J; Anderson SE; Rom WN; Jacobson DR
J Natl Cancer Inst; 1995 Jul; 87(14):1056-60. PubMed ID: 7616596
[TBL] [Abstract][Full Text] [Related]
35. Combined point mutations in codon 12 and 13 of KRAS oncogene in prostate carcinomas.
Silan F; Gultekin Y; Atik S; Kilinc D; Alan C; Yildiz F; Uludag A; Ozdemir O
Mol Biol Rep; 2012 Feb; 39(2):1595-9. PubMed ID: 21607617
[TBL] [Abstract][Full Text] [Related]
36. Comparison of K-ras point mutations at codon 12 and p21 expression in pancreatic cancer between Japanese and Chinese patients.
Song MM; Nio Y; Dong M; Tamura K; Furuse K; Tian YL; He SG; Shen K
J Surg Oncol; 2000 Nov; 75(3):176-85. PubMed ID: 11088049
[TBL] [Abstract][Full Text] [Related]
37. [Prevalence of K-ras gene mutations in human colorectal cancers].
Hayakumo T; Azuma T; Nakajima M; Yasuda K; Cho E; Mukai H; Mizuma Y; Ashihara T; Mizuno S; Hirano S
Nihon Shokakibyo Gakkai Zasshi; 1991 Aug; 88(8):1539-44. PubMed ID: 1942608
[TBL] [Abstract][Full Text] [Related]
38. Ras gene mutation and amplification in human nonmelanoma skin cancers.
Pierceall WE; Goldberg LH; Tainsky MA; Mukhopadhyay T; Ananthaswamy HN
Mol Carcinog; 1991; 4(3):196-202. PubMed ID: 2064725
[TBL] [Abstract][Full Text] [Related]
39. Detection of K-ras mutations in pancreatic and hepatic neoplasms by non-isotopic mismatched polymerase chain reaction.
Stork P; Loda M; Bosari S; Wiley B; Poppenhusen K; Wolfe H
Oncogene; 1991 May; 6(5):857-62. PubMed ID: 1646989
[TBL] [Abstract][Full Text] [Related]
40. A universal method for the mutational analysis of K-ras and p53 gene in non-small-cell lung cancer using formalin-fixed paraffin-embedded tissue.
Sarkar FH; Valdivieso M; Borders J; Yao KL; Raval MM; Madan SK; Sreepathi P; Shimoyama R; Steiger Z; Visscher DW
Diagn Mol Pathol; 1995 Dec; 4(4):266-73. PubMed ID: 8634783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
